6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine
C260H164N10O10 — CID 160781796
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine
6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine (PubChem CID 160781796) has the molecular formula C260H164N10O10 and a molecular weight of 3588.23 g/mol. Its IUPAC name is 6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine.
Molecular Properties
| Compound Name | 6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine |
|---|---|
| PubChem CID | 160781796 |
| Molecular Formula | C260H164N10O10 |
| Molecular Weight | 3588.23 g/mol |
| Exact Mass | 3585.26 |
| IUPAC Name | 6,17-bis(9,9-dimethyl-7-phenylfluoren-2-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaene;7,17-bis(3-phenylphenyl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4(9),5,7,11,15(20),16,18-nonaene;2,4-diphenyl-6-[3-(17-phenyl-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl)phenyl]pyrimidine;4-[17-(2,6-diphenylpyrimidin-4-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]-2,6-diphenylpyrimidine;4-[3-[17-[3-(2,6-diphenylpyrimidin-4-yl)phenyl]-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4(9),5,7,11,14(19),15,17-nonaen-6-yl]phenyl]-2,6-diphenylpyrimidine |
| SMILES | CC1(C)c2cc(-c3ccccc3)ccc2-c2ccc(-c3ccc4c(c3)oc3c4ccc4c5ccc(-c6ccc7c(c6)C(C)(C)c6cc(-c8ccccc8)ccc6-7)cc5oc43)cc21.c1ccc(-c2cc(-c3ccc4c(c3)oc3c4ccc4c5ccc(-c6cc(-c7ccccc7)nc(-c7ccccc7)n6)cc5oc43)nc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3cccc(-c4ccc5c(c4)oc4c5ccc5c6ccc(-c7cccc(-c8cc(-c9ccccc9)nc(-c9ccccc9)n8)c7)cc6oc54)c3)nc(-c3ccccc3)n2)cc1.c1ccc(-c2ccc3c(c2)oc2c3ccc3c4ccc(-c5cccc(-c6cc(-c7ccccc7)nc(-c7ccccc7)n6)c5)cc4oc32)cc1.c1ccc(-c2cccc(-c3ccc4c(c3)oc3cc5oc6cc(-c7cccc(-c8ccccc8)c7)ccc6c5cc34)c2)cc1 |
| InChI | InChI=1S/C62H38N4O2.C60H42O2.C50H30N4O2.C46H28N2O2.C42H26O2/c1-5-15-39(16-6-1)53-37-55(65-61(63-53)41-19-9-3-10-20-41)47-25-13-23-43(33-47)45-27-29-49-51-31-32-52-50-30-28-46(36-58(50)68-60(52)59(51)67-57(49)35-45)44-24-14-26-48(34-44)56-38-54(40-17-7-2-8-18-40)64-62(66-56)42-21-11-4-12-22-42;1-59(2)51-29-37(35-11-7-5-8-12-35)15-21-43(51)45-23-17-39(31-53(45)59)41-19-25-47-49-27-28-50-48-26-20-42(34-56(48)62-58(50)57(49)61-55(47)33-41)40-18-24-46-44-22-16-38(36-13-9-6-10-14-36)30-52(44)60(3,4)54(46)32-40;1-5-13-31(14-6-1)41-29-43(53-49(51-41)33-17-9-3-10-18-33)35-21-23-37-39-25-26-40-38-24-22-36(28-46(38)56-48(40)47(39)55-45(37)27-35)44-30-42(32-15-7-2-8-16-32)52-50(54-44)34-19-11-4-12-20-34;1-4-11-29(12-5-1)33-19-21-36-38-23-24-39-37-22-20-34(27-43(37)50-45(39)44(38)49-42(36)26-33)32-17-10-18-35(25-32)41-28-40(30-13-6-2-7-14-30)47-46(48-41)31-15-8-3-9-16-31;1-3-9-27(10-4-1)29-13-7-15-31(21-29)33-17-19-35-37-25-38-36-20-18-34(24-40(36)44-42(38)26-41(37)43-39(35)23-33)32-16-8-14-30(22-32)28-11-5-2-6-12-28/h1-38H;5-34H,1-4H3;1-30H;1-28H;1-26H |
| InChIKey | SARGLGRYFMRYNE-UHFFFAOYSA-N |
| XLogP | 71.00 |
| TPSA | 260.30 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 280 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3588.23 |
| LogP ≤ 5 | 71.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160781796 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.